Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.3 USD | +1.13% | +25.12% | +59.16% |
01/05 | UBS Adjusts Tenet Healthcare Price Target to $150 From $137, Maintains Buy Rating | MT |
01/05 | RBC Raises Tenet Healthcare Price Target to $136 From $109, Maintains Outperform Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its low valuation, with P/E ratio at 4.45 and 13.61 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has a low valuation given the cash flows generated by its activity.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+59.16% | 11.75B | C+ | ||
+13.70% | 80.61B | C+ | ||
-29.20% | 70.18B | B- | ||
+9.86% | 29.08B | C+ | ||
-11.43% | 16.97B | B | ||
-0.43% | 16.96B | A- | ||
-0.31% | 15.26B | A- | ||
+3.42% | 12.41B | A- | ||
-30.70% | 11.95B | - | - | |
-6.75% | 11.93B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- THC Stock
- Ratings Tenet Healthcare Corporation